OptimizeRx OPRX Finite-Lived Intangible Assets - Expected Amortization Expense (Year Five)
Finite-Lived Intangible Assets - Expected Amortization Expense (Year Five) at other companies
Other financials
Where this comes from
Reported directly by OptimizeRx in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive.
The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about OptimizeRx's finite-lived intangible assets - expected amortization expense (year five).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OptimizeRx's finite-lived intangible assets - expected amortization expense (year five)?
- OptimizeRx (OPRX) reported finite-lived intangible assets - expected amortization expense (year five) of $21.72M in Q1 2026.
- What is the long-term trend for OptimizeRx's finite-lived intangible assets - expected amortization expense (year five)?
- Over 4 years (2020 to 2024), OptimizeRx's finite-lived intangible assets - expected amortization expense (year five) has grown at a 46.0% compound annual growth rate (CAGR), from $5.63M to $25.58M.